Seres Therapeutics (MCRB) Technical (Analysis) Reports Seres Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Seres Therapeutics (MCRB)
Technical Analysis Report for NASDAQ stock MCRB Seres Therapeutics. Dated: 28 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock MCRB Seres Therapeutics then click here. or read Experts views on Seres Therapeutics or Forecast & share price targets of Seres Therapeutics
Seres Therapeutics Opened at 3.49 and Closed at: 3.52, which is 0% of previous session's close. It moved within a range of 3.41 and 3.55
The session was a Bullish session with an average volume of 55400, which is -0.36% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
A Dead cross was found 7 days back on short term averages
A Dead cross was found 7 days back on mid term averages
Support for tomorrow is 3.47 and resistance for tomorrow is 3.61
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 3.44, 3.35 resistance for tomorrow's hourly charts is 3.58, 3.63
10 Day SMA for Seres Therapeutics (MCRB) is 3.95 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Seres Therapeutics (MCRB) is 4.61 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Seres Therapeutics (MCRB) is 4.74 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 5.86 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Seres Therapeutics is 8.57 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Seres Therapeutics is at 4.61 and 200 DMA is at 8.57, while 50 DMA and 100 DMA are at 4.74 and 5.86 respectively
Seres Therapeutics (MCRB) moving average of 20 SMA is at 4.61 and 20 EMA is at 4.32
| Date | Closing Price | 20 SMA | 20 EMA |
| 28 Mon Sep | 3.52 | 4.61 | 4.32 |
| 25 Fri Sep | 3.52 | 4.69 | 4.4 |
| 24 Thu Sep | 3.62 | 4.76 | 4.49 |
| 23 Wed Sep | 3.79 | 4.81 | 4.58 |
| 22 Tue Sep | 4.02 | 4.87 | 4.66 |
| 21 Mon Sep | 4.07 | 4.91 | 4.73 |
Seres Therapeutics (MCRB) moving average of 50 SMA is at 4.74 and 50 EMA is at 4.89
| Date | Closing Price | 50 SMA | 50 EMA |
| 28 Mon Sep | 3.52 | 4.74 | 4.89 |
| 25 Fri Sep | 3.52 | 4.78 | 4.95 |
| 24 Thu Sep | 3.62 | 4.81 | 5.01 |
| 23 Wed Sep | 3.79 | 4.84 | 5.07 |
| 22 Tue Sep | 4.02 | 4.88 | 5.12 |
| 21 Mon Sep | 4.07 | 4.9 | 5.17 |
Seres Therapeutics (MCRB) moving average of 100 SMA is at 5.86 and 100 EMA is at 5.98
| Date | Closing Price | 100 SMA | 100 EMA |
| 28 Mon Sep | 3.52 | 5.86 | 5.98 |
| 25 Fri Sep | 3.52 | 5.9 | 6.03 |
| 24 Thu Sep | 3.62 | 5.95 | 6.08 |
| 23 Wed Sep | 3.79 | 5.99 | 6.13 |
| 22 Tue Sep | 4.02 | 6.02 | 6.18 |
| 21 Mon Sep | 4.07 | 6.06 | 6.22 |
Seres Therapeutics (MCRB) moving average of 200 SMA is at 8.57 and 200 EMA is at 7.51
| Date | Closing Price | 200 SMA | 200 EMA |
| 28 Mon Sep | 3.52 | 8.57 | 7.51 |
| 25 Fri Sep | 3.52 | 8.63 | 7.55 |
| 24 Thu Sep | 3.62 | 8.7 | 7.59 |
| 23 Wed Sep | 3.79 | 8.77 | 7.63 |
| 22 Tue Sep | 4.02 | 8.83 | 7.67 |
| 21 Mon Sep | 4.07 | 8.9 | 7.71 |
Seres Therapeutics has performed better than Xenetic Biosciences in short term. Holding Seres Therapeutics could be a better choice for now!
Veracyte Inc has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Veracyte Inc, about 33.03% more returns!
Spero Therapeutics has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Spero Therapeutics, about 25.85% more returns!
Solid Biosciences has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Solid Biosciences, about 4.3% more returns!
Phio Pharmaceuticals has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 20.97% more returns!
Petmed Express has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Petmed Express, about 2.91% more returns!
Minerva Neurosciences has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Minerva Neurosciences, about 2.87% more returns!
Aceto Corporation has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Aceto Corporation, about 1.3% more returns!
Axogen Inc has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Axogen Inc, about 13.73% more returns!
Biotelemetry Inc has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Biotelemetry Inc, about 7.03% more returns!
Seres Therapeutics has performed better than Cellectis S in short term. Holding Seres Therapeutics could be a better choice for now!
Diamedica Therapeutics has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Diamedica Therapeutics, about 59.33% more returns!
Immucell Corporation has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Immucell Corporation, about 29.23% more returns!
Icu Medical has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Icu Medical, about 23.15% more returns!
Immuron has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Immuron, about 32.81% more returns!
Inogen Inc has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Inogen Inc, about 29.61% more returns!
Inovio Pharmaceuticals has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Inovio Pharmaceuticals, about 20.44% more returns!
Meiragtx Holdings has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Meiragtx Holdings, about 8.76% more returns!
Seres Therapeutics Technical analysis of indicators
Price action analysis of Seres Therapeutics (MCRB) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Seres Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Seres Therapeutics in short term and the sell signal is strong.
Seres Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Seres Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Seres Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.92 and Seres Therapeutics MCRB stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Seres Therapeutics MCRB stock. Volume based technical analysis of Seres Therapeutics MCRB stock is negative.
Seres Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock MCRB Seres Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And MCRB Experts View which covers a lot of information including buying and selling signals
MCRB future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Seres Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Seres Therapeutics (MCRB) Technical (Analysis) Reports Seres Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


